Belgium· BE-AMP-SAM241017-00

Copegus 200 mg

A ribavirin product containing ribavirin, registered in Belgium by Roche. The same ATC class is registered in 10 of our 19 countries.

ATC J05AP01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedCopegus 200 mgATCJ05AP01REGISTER NO.BE-AMP-SAM241017-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Ribavirin is registered in 10 of 19 countries.

Countries holding a registration under ATC J05AP01 (ribavirin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose

Ribavirin · ATC J05AP01

10 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Germany
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ribavirin
Manufacturer
Roche
Country
Belgium (BE)
ATC code
J05AP01
ATC class
Ribavirin
Defined daily dose
6 g, Inhal
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    1713569
  • be_apb
    0774406

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

143 interactions on record for ribavirin.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ribavirin · interactions on record

143 records

  • 4 severe
  • 4 moderate
  • 135 info

Most severe, free to view

  • MercaptopurineL01BB02severe
  • BexaroteneL01XF03severe
  • BexarotenL01XX25severe
  • AzathioprineL04AX01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ribavirin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ribavirin products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Cyprus · Ribavirin Aurobindo
  • Germany · Ribavirin Ratiopharm
  • Spain · Ribavirina Normon
  • France · Ribavirine Pharmadev, Ribavirine Skyepharma
  • United Kingdom (Northern Ireland) · Ribavirin Milpharm
  • Italy · Ribavirina Aurobindo
  • Netherlands · Ribavirine Ratiopharm
  • Portugal · Ribavirina Aurobindo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3addfda3-f42b-43cf-b11e-daa6514489b8
GET /v1/drugs/3addfda3-f42b-43cf-b11e-daa6514489b8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Copegus 200 mg",
  "name_fr": "Copegus 200 mg",
  "name_nl": "Copegus 200 mg",
  "amp_code": "SAM241017-00",
  "strengths": [
    "200.0000",
    "200.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Ribavirin"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ribavirin",
  "authorisation_numbers": [
    "BE241017"
  ]
}

See everything about ribavirin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.